LOL why do I post anything? Thats a good question.
Post# of 148282
If HIV BLA delay is solely a spreadsheet reformatting issue, CYDY is huge bargain at $1 billion dollar market cap, for HIV alone.
But I simply cannot figure out what factual reallity is compatible with Cytodyn's public statements.
I am unable to convince myself that the HIV BLA delay is primarily an administrative issue.